Pharm2Farm is part of Nanosynth Group plc. Nanosynth currently has two operating subsidiaries, Pharm2Farm Ltd and Virosynth Ltd, and focus on nanotechnology on advanced materials.

Pharm2Farm has worldwide licenses for two patents relating to nanoparticle production and has filed two additional patents. Pharm2Farm produce and sell these products through a licence to this technology from Nottingham Trent University, UK.

Bespoke Nano

Pharm2Farm has developed and patented a process to produce nanoparticles for several applications. This uses bespoke nanotechnology coating processes to dramatically increase the performance of nanoparticles across applications in comparison to standard methodologies.